Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
0.31%
↑ 101% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-46.46%
Historical baseline
PeriodValue
Q4 20250.31%
Q3 20259.50%
Q2 20259.27%
Q1 20255.69%
Q4 2024-4.61%
Q3 20248.12%
Q2 20243.79%
Q1 2024-8.03%
Q4 2023-4.85%
Q3 2023-0.31%
Q2 2023-5.29%
Q1 2023-10.77%
Q4 2022-3.06%
Q3 2022-2.25%
Q2 20223.43%
Q1 20224.72%
Q4 2021-15.43%
Q3 2021-36.19%
Q2 2021-500.96%
Q1 202166.54%
Q4 2020-32.11%
Q3 2020-18.44%
Q2 2020-13.45%
Q1 2020-744.23%
Q4 2019-99.44%
Q3 2019-101.80%
Q2 201942.72%
Q1 201999.86%
Q4 20180.00%